Credit Suisse’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Credit Suisse’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-490,900	Closed	-$55M	–	4398
2021 Q4	$55M	Sell	490,900 -195,100	-28%	-$23.5M	0.03%	593
2021 Q3	$86.2M	Buy	686,000 +77,000	+13%	+$9.92M	0.05%	415
2021 Q2	$82.5M	Sell	609,000 -73,000	-11%	-$9.6M	0.04%	457
2021 Q1	$92.5M	Buy	682,000 +246,200	+56%	+$36.9M	0.05%	437
2020 Q4	$61.4M	Sell	435,800 -181,400	-29%	-$23.2M	0.03%	613
2020 Q3	$68.8M	Buy	617,200 +103,600	+20%	+$11.6M	0.04%	480
2020 Q2	$57.5M	Buy	513,600 +366,000	+248%	+$36M	0.04%	481
2020 Q1	$11.4M	Sell	147,600 -401,400	-73%	-$35.5M	0.01%	1113
2019 Q4	$52.2M	Buy	549,000 +120,000	+28%	+$10.4M	0.04%	530
2019 Q3	$32.7M	Sell	429,000 -149,100	-26%	-$12.4M	0.03%	651
2019 Q2	$50.7M	Buy	578,100 +12,400	+2%	+$1.06M	0.04%	440
2019 Q1	$51.2M	Buy	565,700 +365,400	+182%	+$31.1M	0.05%	414
2018 Q4	$14.4M	Buy	+200,300	New	+$16.1M	0.02%	964
2018 Q3	–	Sell	-300,000	Closed	-$28.6M	–	4016
2018 Q2	$28.6M	Buy	+300,000	New	+$27.6M	0.03%	645
2017 Q2	–	Sell	-15,000	Closed	-$1.04M	–	3979
2017 Q1	$1.04M	Buy	+15,000	New	+$1.01M	﹤0.01%	2836

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Credit Suisse's XBI Position: Q1 2024 in Review

Credit Suisse reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 91% in Q1 2024, selling an estimated $21.1M and leaving 23,460 shares worth $2.23M. The position accounts for ﹤0.01% of the portfolio, ranked #1778.

Credit Suisse first reported a position in XBI in Q2 2013 and has held it in 44 quarters since. The position peaked at $124M in Q3 2015. 780 funds tracked by Wall St. Rank hold XBI as of Q1 2024.

Credit Suisse held 23,460 shares of State Street SPDR S&P Biotech ETF worth $2.23M as of Q1 2024.
Credit Suisse sold 227,868 State Street SPDR S&P Biotech ETF shares in Q1 2024, an estimated $21.1M.
State Street SPDR S&P Biotech ETF made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #1778 holding.
Credit Suisse first reported a position in State Street SPDR S&P Biotech ETF in Q2 2013 and has held it in 44 quarters since.
Credit Suisse's State Street SPDR S&P Biotech ETF position peaked at $124M in Q3 2015.
780 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.